Cytokine Inflammatory Mediators and Mucin Regulation in Middle Ear Epithelium

中耳上皮细胞因子炎症介质和粘蛋白调节

• 批准号: 8874947
• 负责人: JOSEPH E KERSCHNER
• 金额: $ 32.07万
• 依托单位: MEDICAL COLLEGE OF WISCONSIN
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-01 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8874947
• 关键词: Acute; Affect; Age; Animal Model; Animals; Antibiotic Therapy; Antibiotics; Basic Science; Brain Abscess; Cell Culture Techniques; Cells; Child; Child Care; Chinchilla (genus); Chronic; Clinical; Data; Development; Developmental Delay Disorders; Diagnosis; Disease; Epithelium; G-Protein-Coupled Receptors; Gel; Gene Expression; Genetic Transcription; Goals; Health Expenditures; Healthcare; Healthcare Systems; Hearing; Hypertrophy; Immunity; In Vitro; Infection; Infiltration; Inflammation Mediators; Inflammatory; Intervention; Investigation; Knock-out; Knockout Mice; Laboratory Finding; Language; Lead; Life; Liquid substance; MUC5AC gene; MUC5B gene; Measurable; Meningitis; MicroRNAs; Microbial Biofilms; Modeling; Molecular; Muc 2 protein; Mucins; Mucous Membrane; Mus; Operative Surgical Procedures; Otitis Media; Pathogenesis; Pathway interactions; Patients; Physicians; Production; Regulation; Research; Resources; Specimen; Speech; Techniques; Time; Tympanic membrane; United States; Up-Regulation; Visit; antimicrobial; aquaporin 5; cytokine; ear infection; hearing impairment; microbial; middle ear; novel; pathogen; pediatric patients; research study; response; water channel

DESCRIPTION (provided by applicant): Otitis media (OM) is the most common diagnosis in pediatric patients who visit physicians for illness in the United States [1-2], affects more than 90% of all children by the age of 5 [3-4], is the most common indication for antimicrobial therapy in children [5], is the most common cause of hearing loss in young children and can lead to speech, language, educational and other developmental delays [6]. Treatment of OM also consumes significant health care resources as OM is responsible for approximately $5 billion annually in health care expenditures in the U.S., is the most common cause for surgical procedures in young children [4,7-8], and is associated with life-threatening complications such as meningitis and brain abscess formation [9- 10]. Given these factors, a more thorough understanding of OM through basic science investigation is required to provide potential novel and efficacious interventions. Specifically, gel-forming mucins (GFM), produced by middle ear mucosa (MEM), are known to be the primary cause of hearing loss which develops in children with chronic OM and mucins are also known to be critically important in ME mucosal protective functions and immunity. Very little has been achieved in developing an understanding of the regulation of mucins in MEM and even less in correlating laboratory findings to bedside observations in patients suffering from OM. Answering the questions posed by our Central Hypothesis that specific host and pathogen factors influence mucosal changes to regulate GFM in the middle ear will allow significant enhancement in our understanding ME mucin function and regulation in relation to OM pathogenesis. The current proposal will include clinical specimens from children with chronic OM, animal models and in vitro cell culture models and employ molecular techniques to answer these fundamental questions: 1) What is the relationship of specific GFM to hearing loss in children, 2) Are there measurable changes in the MEM of children with chronic OM that correlate with changes in GFM?, 3) Does utilization of antibiotic therapy have a meaningful effect on GFM?, 4) What is the impact of biofilm formation on GFM in the ME space?, 5) In patients with chronic OM, do any of the primary OM pathogens: NTHi, SP or Mcat differentially regulate increased GFM production, 6) Does aquaporin 5 impact GFM regulation and 7) Is there a correlation between GFM expression and polymicrobial infection of OM pathogens? Data generated through this proposal will provide answers to these questions and will continue to advance our long-term goal of developing novel interventions in OM pathogenesis through modulation of mucin production pathways.

描述（由申请人提供）：中耳炎 (OM) 是美国因病就医的儿科患者中最常见的诊断 [1-2]，影响 90% 以上的 5 岁儿童 [3 -4]，是儿童抗菌治疗最常见的适应症[5]，是幼儿听力损失的最常见原因，可导致言语、语言、教育和其他发育迟缓[6]。 OM 的治疗还消耗大量的医疗保健资源，因为 OM 每年约占美国医疗保健支出 50 亿美元，是幼儿手术的最常见原因 [4,7-8]，并且与生命相关-威胁性并发症，如脑膜炎和脑脓肿形成[9-10]。鉴于这些因素，需要通过基础科学研究更深入地了解 OM，以提供潜在的新颖且有效的干预措施。具体来说，中耳粘膜 (MEM) 产生的凝胶形成粘蛋白 (GFM) 是慢性 OM 儿童听力损失的主要原因，粘蛋白在 ME 粘膜保护功能中也至关重要和免疫力。在了解 MEM 中粘蛋白的调节方面进展甚微，在将实验室检查结果与 OM 患者的床边观察联系起来方面更是进展甚微。回答我们的中心假设提出的问题，即特定宿主和病原体因素影响粘膜变化以调节中耳的 GFM，将显着增强我们对 ME 粘蛋白功能和与 OM 发病机制相关的调节的理解。目前的提案将包括慢性 OM 儿童的临床标本、动物模型和体外细胞培养模型，并采用分子技术来回答以下基本问题：1）特定 GFM 与儿童听力损失之间的关系是什么，2）是否存在慢性 OM 儿童 MEM 的可测量变化与 GFM 变化相关？, 3) 抗生素治疗的使用对 GFM 有有意义的影响吗？, 4) 生物膜形成对 ME 中 GFM 的影响是什么？空间？，5) 在慢性 OM 患者中，任何主要 OM 病原体：NTHi、SP 或 Mcat 是否会差异调节 GFM 产生的增加，6) 水通道蛋白 5 是否影响 GFM 调节，7) GFM 表达与多种微生物之间是否存在相关性？ OM病原体感染？通过该提案产生的数据将为这些问题提供答案，并将继续推进我们的长期目标，即通过调节粘蛋白产生途径开发针对 OM 发病机制的新型干预措施。